<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04548232</url>
  </required_header>
  <id_info>
    <org_study_id>123100004250085347</org_study_id>
    <nct_id>NCT04548232</nct_id>
  </id_info>
  <brief_title>LSG in Obese Patients</brief_title>
  <official_title>Shanghai Tenth People's Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      297 patients with obesity and 43 healthy individuals with normal BMI were enrolled. 82&#xD;
      patients underwent LSG. Anthropometrics, glucose-lipid metabolic markers, and hepatic&#xD;
      steatosis assessed by FibroScan(CAP value and E value) were measured baseline, and again at a&#xD;
      time interval of 6 months and 1 year follow up after surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>hepatic steatosis</measure>
    <time_frame>2017-2019</time_frame>
  </primary_outcome>
  <enrollment type="Actual">297</enrollment>
  <condition>Obesity</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LSG</intervention_name>
    <description>bariatric surgery</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        297 subjects with obesity or overweight&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1) age ranged from 16~65 years old, 2) BMI over 37.5 kg/m2, or BMI over 32.5 kg/m2 with&#xD;
        diabetes which meets the recommended cutoff for bariatric surgery of the Guidelines for&#xD;
        surgical treatment of obesity accompanied with or without type 2 diabetes in China. -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1) secondary cause of obesity such as hypothalamic obesity, Cushing syndrome, and&#xD;
             hypophysis dysfunction, etc., 2) pregnancy or lactation, 3) contraindications for&#xD;
             laparoscopic surgery, such as gastrointestinal diseases of intra-abdominal infection,&#xD;
             adhesions, etc., 4) severe heart, liver and kidney dysfunction, 5) organic and&#xD;
             systemic diseases intolerant of surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 7, 2020</study_first_submitted>
  <study_first_submitted_qc>September 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>September 7, 2020</last_update_submitted>
  <last_update_submitted_qc>September 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Shen Qu</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

